{"id":"diacetazotol","rwe":[],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"unknown","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"dimazon","offLabel":[],"synonyms":["diacetazotol","diacetotoluide","diacetylaminoazotoluene","dimazon","epithelone","dermagan"],"timeline":[],"approvals":[],"brandName":"Dimazon","ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"Imagine Dimazon as a key that fits into a lock on a cell. When it binds to its target, it can either turn the lock on or off, depending on the cell's needs. This can help to regulate various cellular processes and treat certain diseases.","oneSentence":"Dimazon works by binding to a specific target, although its exact mechanism of action is currently unknown.","technicalDetail":"Dimazon's mechanism of action is not well understood, but it is believed to involve the inhibition of a specific enzyme or receptor, leading to downstream effects on cellular signaling pathways."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3724","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=diacetazotol","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T10:38:03.586727","biosimilars":[],"competitors":[],"genericName":"diacetazotol","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"U1925T7L3Z","CHEBI":"CHEBI:81046","UMLSCUI":"C0057669","PUBCHEM_CID":"6751","MESH_SUPPLEMENTAL_RECORD_UI":"C029040"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"Dimazon (diacetazotol) is a small molecule drug with unknown target and drug class. Its commercial status is unclear, and it is not known whether it is FDA approved or off-patent. There is limited information available on its approved indications, half-life, and bioavailability. Further research is needed to understand its mechanism of action and key safety considerations. As a result, Dimazon is not widely recognized in the pharmaceutical industry.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}